Itinerant Ferromagnetism in layered crystals LaCoOX (X = P, As)

The electronic and magnetic properties of cobalt-based layered oxypnictides, LaCoOX (X = P, As), are investigated. LaCoOP and LaCoOAs show metallic type conduction, and the Fermi edge is observed by hard x-ray photoelectron spectroscopy. Ferromagnetic transitions occur at 43 K for LaCoOP and 66 K for LaCoOAs. Above the transition temperatures, temperature dependence of the magnetic susceptibility follows the Curie-Weiss law. X-ray magnetic circular dichroism (XMCD) is observed at the Co L2,3-edge, but not at the other edges. The calculated electronic structure shows a spin polarized ground state. These results indicate that LaCoOX are itinerant ferromagnets and suggest that their magnetic properties are governed by spin fluctuation.Comment: 16 pages, 9 figures, Physical Review B, in press. Received 17 February 2008. Accepted 29 May 200

Spin Dynamics in Iron-based Layered Superconductor (La_{0.87}Ca_{0.13})FePO Revealed by ^{31}P and ^{139}La NMR Studies

We report ^{31}P and ^{139}La NMR studies of (La_{0.87}Ca_{0.13})FePO, which is a family member of the recently discovered superconductor LaFeAs(O_{1-x}F_x). In the normal state, Knight shift and $1/T_1T$ show that a Fermi-liquid state with moderate ferromagnetic fluctuations emerges below 30K. From 1/T_1T of ^{31}P and ^{139}La, quasi-two dimensional electronic structure is suggested, in which the FeP layer is more conductive than the LaO layer. In the superconducting (SC) state, although a clear Meissner signal was observed, 1/T_1T increases below T_c, in contrast to a decrease of 1/T_1T due to the opening of a SC gap, suggesting that novel low-energy spin dynamics develop in the SC state.Comment: Phys. Rev. Lett. 101, 077006 (2008

Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients

Chronic hepatitis B (CHB) leads to cirrhosis and hepatocellular carcinoma (HCC). With a cohort of 1,206 CHB patients who visited Okayama University Hospital and related hospitals in 2011 and 2012, we compared the incidence rates of HCC among the patients grouped by age, hepatitis B virus (HBV) DNA, hepatitis B e antigen (HBeAg), and treatment. HCCs were observed in 115 patients with the median observation period of 1,687 days. Among the HCC patients aged ≥ 35 years, HBV DNA ≥ 4 log copies/mL and positive HBeAg at diagnosis (n=184), the HCC incidence rate was 8.4% at 5 years in the entecavir (ETV)-treated patients, 21.8% in the lamivudine (LVD)-treated patients, and 26.4% among the patients not treated with drugs. The cumulative HCC incidence was significantly reduced in the ETV-treated patients compared to those treated with LVD or not treated (p=0.013). Among the patients aged ≥ 35 years with HBV DNA ≥ 4 log copies/mL and negative HBeAg (n=237), the cumulative HCC incidence was 14.6% in 5 years in ETV group and 13.9% among those not treated with a drug (p>0.05). Only small numbers of HCCs occurred in other patients. In CHB patients aged≥35 years with HBV DNA ≥4 log copies/mL and positive HBeAg, ETV treatment is recommended for the suppression of HCC development

Mixed HCV Infection of Genotype 1B and Other Genotypes Influences Non-response during Daclatasvir + Asunaprevir Combination Therapy

Daclatasvir (DCV) + asunaprevir (ASV) combination therapy has become available for patients with hepatitis C virus (HCV) serogroup 1 infection. We studied the efficacy of this therapy by focusing on the factors associated with sustained virological responses (SVR) including resistance-associated variants (RAVs) and mixed infection of different HCV genotypes. We enrolled 951 HCV serogroup 1-positive patients who received this combination therapy at our hospital or affiliated hospitals. The presence of RAVs in non-structural (NS) regions 3 and 5A was analyzed by direct sequencing. HCV genotypes were determined by PCR with genotype-specific primers targeting HCV core and NS5B regions. SVR was achieved in 91.1% of patients. Female sex, age > 70 years, and RAVs were significantly associated with non-SVR (p<0.01 for all). Propensity score-matching results among the patients without RAVs regarding sex, age, and fibrosis revealed that mixed HCV infection determined by HCV NS5B genotyping showed significantly lower SVR rates than 1B-mono infection (p=0.02). Female sex and RAVs were significant factors associated with treatment failure of this combination therapy for patients with HCV serogroup 1 infection. Mixed HCV infection other than 1B-mono infection would be useful for predicting treatment failure

High-Throughput Cryopreservation of Plant Cell Cultures for Functional Genomics

Suspension-cultured cell lines from plant species are useful for genetic engineering. However, maintenance of these lines is laborious, involves routine subculturing and hampers wider use of transgenic lines, especially when many lines are required for a high-throughput functional genomics application. Cryopreservation of these lines may reduce the need for subculturing. Here, we established a simple protocol for cryopreservation of cell lines from five commonly used plant species, Arabidopsis thaliana, Daucus carota, Lotus japonicus, Nicotiana tabacum and Oryza sativa. The LSP solution (2 M glycerol, 0.4 M sucrose and 86.9 mM proline) protected cells from damage during freezing and was only mildly toxic to cells kept at room temperature for at least 2 h. More than 100 samples were processed for freezing simultaneously. Initially, we determined the conditions for cryopreservation using a programmable freezer; we then developed a modified simple protocol that did not require a programmable freezer. In the simple protocol, a thick expanded polystyrene (EPS) container containing the vials with the cell–LSP solution mixtures was kept at −30°C for 6 h to cool the cells slowly (pre-freezing); samples from the EPS containers were then plunged into liquid nitrogen before long-term storage. Transgenic Arabidopsis cells were subjected to cryopreservation, thawed and then re-grown in culture; transcriptome and metabolome analyses indicated that there was no significant difference in gene expression or metabolism between cryopreserved cells and control cells. The simplicity of the protocol will accelerate the pace of research in functional plant genomics

Significant suppression of weak ferromagnetism in (La1.8{}_{1.8}Eu0.2{}_{0.2})CuO4{}_4

The magnetic structure of (La${}_{1.8}$Eu${}_{0.2}$)CuO${}_4$ has been studied by magnetization measurements of single crystals, which show antiferromagnetic long-range order below $T_N$ = 265 K and a structural phase transition at $T_s$ = 130 K. At $T_s < T < T_N$, the Cu spin susceptibility exhibits almost the same behavior as that of La${}_2$CuO${}_4$ in the low-temperature orthorhombic phase, which indicates the existence of finite spin canting out of the CuO${}_2$ plane. At $T < T_s$, the magnitude of the weak-ferromagnetic moment induced by the spin canting is suppressed approximately by 70{%}. This significant suppression of the weak-ferromagnetic moment is carefully compared with the theoretical analysis of weak ferromagnetism by Stein {\it et al.} (Phys. Rev. B {\bf 53}, 775 (1996)), in which the magnitude of weak-ferromagnetic moments strongly depend on the crystallographic symmetry. Based on such comparison, below $T_s$ (La${}_{1.8}$Eu${}_{0.2}$)CuO${}_4$ is in the low-temperature less-orthorhombic phase with a space group of $Pccn$. We also discuss the possible magnetic structure of the pure low-temperature tetragonal phase with space group $P4_2/{ncm}$, which is relevant for rare-earth and alkaline-earth ions co-doped La${}_2$CuO${}_4$.Comment: 16 pages including 5 figures, submitted to Phys. Rev. B. Fig. 4 is newly adde